GnRH antagonist (Genetics & Ivf Institute)

促性腺释放激素拮抗剂（Genetics & Ivf Institute）

Report date: 2023/01/03 20:00:35

Base Information

Drug NameGnRH antagonist (Genetics & Ivf Institute)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGonadotropin-releasing hormone antagonists
TargetsGonadotropin-releasing hormone
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesGenetics & Ivf Institute
China Registration ClassN/A

Develop Information

Active CompaniesGenetics & Ivf Institute
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A